Literature DB >> 25416031

PAK1 is a novel cardiac protective signaling molecule.

Yunbo Ke1, Xin Wang, Xu Yu Jin, R John Solaro, Ming Lei.   

Abstract

We review here the novel cardiac protective effects of the multifunctional enzyme, p21-activated kinase 1 (PAK1), a member of a serine/threonine protein kinase family. Despite the large body of evidence from studies in noncardiac tissue indicating that PAK1 activity is key in the regulation of a number of cellular functions, the role of PAK1 in the heart has only been revealed over the past few years. In this review, we assemble an overview of the recent findings on PAK1 signaling in the heart, particularly its cardiac protective effects. We present a model for PAK1 signaling that provides a mechanism for specifically affecting cardiac cellular processes in which regulation of protein phosphorylation states by protein phosphatase 2A (PP2A) predominates.We discuss the anti-adrenergic and antihypertrophic cardiac protective effects of PAK1, as well as its role in maintaining ventricular Ca(2+) homeostasis and electrophysiological stability under physiological, β-adrenergic and hypertrophic stress conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25416031     DOI: 10.1007/s11684-014-0380-9

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  23 in total

Review 1.  The genetics of Pak.

Authors:  Clemens Hofmann; Mikhail Shepelev; Jonathan Chernoff
Journal:  J Cell Sci       Date:  2004-09-01       Impact factor: 5.285

2.  A brain serine/threonine protein kinase activated by Cdc42 and Rac1.

Authors:  E Manser; T Leung; H Salihuddin; Z S Zhao; L Lim
Journal:  Nature       Date:  1994-01-06       Impact factor: 49.962

3.  p21-Activated kinase1 (Pak1) is a negative regulator of NADPH-oxidase 2 in ventricular myocytes.

Authors:  Jaime DeSantiago; Dan J Bare; Lei Xiao; Yunbo Ke; R John Solaro; Kathrin Banach
Journal:  J Mol Cell Cardiol       Date:  2013-12-28       Impact factor: 5.000

4.  Functional integrity of the T-tubular system in cardiomyocytes depends on p21-activated kinase 1.

Authors:  Jaime DeSantiago; Dan J Bare; Yunbo Ke; Katherine A Sheehan; R John Solaro; Kathrin Banach
Journal:  J Mol Cell Cardiol       Date:  2013-04-20       Impact factor: 5.000

5.  Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection.

Authors:  Sandrine Lecour; Robert M Smith; Brian Woodward; Lionel H Opie; Luc Rochette; Michael N Sack
Journal:  J Mol Cell Cardiol       Date:  2002-05       Impact factor: 5.000

6.  A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.

Authors:  Zhu-Qiu Jin; Jianqing Zhang; Yong Huang; Holly E Hoover; Donald A Vessey; Joel S Karliner
Journal:  Cardiovasc Res       Date:  2007-06-08       Impact factor: 10.787

7.  Regulation of L-type calcium channel and delayed rectifier potassium channel activity by p21-activated kinase-1 in guinea pig sinoatrial node pacemaker cells.

Authors:  Yunbo Ke; Ming Lei; Thomas P Collins; Stevan Rakovic; Paul A D Mattick; Michiko Yamasaki; Mark S Brodie; Derek A Terrar; R John Solaro
Journal:  Circ Res       Date:  2007-04-05       Impact factor: 17.367

8.  Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.

Authors:  Ulrich Hofmann; Natalie Burkard; Carolin Vogt; Annemarie Thoma; Stefan Frantz; Georg Ertl; Oliver Ritter; Andreas Bonz
Journal:  Cardiovasc Res       Date:  2009-05-05       Impact factor: 10.787

9.  Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes.

Authors:  Kai Mao; Satoru Kobayashi; Zahara M Jaffer; Yuan Huang; Paul Volden; Jonathan Chernoff; Qiangrong Liang
Journal:  J Mol Cell Cardiol       Date:  2007-12-03       Impact factor: 5.000

10.  Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.

Authors:  Wei Liu; Min Zi; Ronald Naumann; Susanne Ulm; Jiawei Jin; Domenico M Taglieri; Sukhpal Prehar; Junhong Gui; Hoyee Tsui; Rui-Ping Xiao; Ludwig Neyses; R John Solaro; Yunbo Ke; Elizabeth J Cartwright; Ming Lei; Xin Wang
Journal:  Circulation       Date:  2011-11-14       Impact factor: 29.690

View more
  9 in total

Review 1.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

Review 2.  Regulation of cardiac gap junctions by protein phosphatases.

Authors:  Ashleigh R Hood; Xun Ai; Steven M Pogwizd
Journal:  J Mol Cell Cardiol       Date:  2017-05-03       Impact factor: 5.000

Review 3.  p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity.

Authors:  Ping Guo; Yufeng Liu; Jingrong Feng; Shihang Tang; Fanyan Wei; Jian Feng
Journal:  Arch Toxicol       Date:  2022-09-18       Impact factor: 6.168

4.  Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo.

Authors:  Ahmad Al-Azayzih; Wided N Missaoui; Brian S Cummings; Payaningal R Somanath
Journal:  Nanomedicine       Date:  2016-03-03       Impact factor: 5.307

Review 5.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 6.  Promoting Glucose Transporter-4 Vesicle Trafficking along Cytoskeletal Tracks: PAK-Ing Them Out.

Authors:  Ragadeepthi Tunduguru; Debbie C Thurmond
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-20       Impact factor: 5.555

7.  Phosphorylation-dependent activity-based conformational changes in P21-activated kinase family members and screening of novel ATP competitive inhibitors.

Authors:  Mehreen Gul; Muhammad Fakhar; Sajid Rashid
Journal:  PLoS One       Date:  2019-11-18       Impact factor: 3.240

Review 8.  Cdc42/Rac Interactive Binding Containing Effector Proteins in Unicellular Protozoans With Reference to Human Host: Locks of the Rho Signaling.

Authors:  Preeti Umarao; Pragyan Parimita Rath; Samudrala Gourinath
Journal:  Front Genet       Date:  2022-02-02       Impact factor: 4.599

Review 9.  Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders.

Authors:  Xun Ai; Jiajie Yan; Steven M Pogwizd
Journal:  Cell Signal       Date:  2021-07-02       Impact factor: 4.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.